People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other Technology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Veritas Genetics International Ltd. | — | Other Technology | Series B | $30.3M | $141.4M | 2016 |
| Beryllium, LLC | — | Pharmaceuticals | Series A | $11.5M | $232.3M | 2009 |
| Abvitro Inc | — | Other | Seed | $2.6M | $34.8M | 2012 |
Mirza Cifric at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mirza Cifric on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Judith Li | 1 | 8 |
| Casey Cunningham | 1 | 7 |
| Peter Parker | 1 | 6 |
| Brian Hubbard | 1 | 4 |
| Ann Merrifield | 1 | 3 |
| Jeffrey Newton | 1 | 3 |
| Neil Weir | 1 | 2 |
| Lance Stewart | 1 | 2 |
| Johan Pontin | 1 | 1 |
| Julie Sharkey | 1 | 1 |
| Douglas Flood | 1 | 1 |
| Christopher Wilfong | 1 | 1 |
| Francois Vigneault | 1 | 1 |
| Kevin Lelande | 1 | 1 |
| Brent Bannerman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.